Korro Bio, Inc. (KRRO)
NASDAQ: KRRO · IEX Real-Time Price · USD
45.57
-1.41 (-3.00%)
At close: Jul 19, 2024, 4:00 PM
45.54
-0.03 (-0.07%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Korro Bio Statistics

Total Valuation

Korro Bio has a market cap or net worth of $422.57 million. The enterprise value is $316.14 million.

Market Cap 422.57M
Enterprise Value 316.14M

Important Dates

The next estimated earnings date is Tuesday, August 27, 2024, before market open.

Earnings Date Aug 27, 2024
Ex-Dividend Date n/a

Share Statistics

Korro Bio has 9.27 million shares outstanding. The number of shares has increased by 2,853.58% in one year.

Shares Outstanding 9.27M
Shares Change (YoY) +2,853.58%
Shares Change (QoQ) +424.39%
Owned by Insiders (%) 7.66%
Owned by Institutions (%) 72.04%
Float 2.26M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio n/a
Forward PS n/a
PB Ratio 2.79
P/FCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 13.18, with a Debt / Equity ratio of 0.24.

Current Ratio 13.18
Quick Ratio n/a
Debt / Equity 0.24
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -338.61

Financial Efficiency

Return on equity (ROE) is -80.50% and return on invested capital (ROIC) is -45.64%.

Return on Equity (ROE) -80.50%
Return on Assets (ROA) -59.50%
Return on Capital (ROIC) -45.64%
Revenue Per Employee n/a
Profits Per Employee -$795,941
Employee Count 102
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, Korro Bio has paid $20,000 in taxes.

Income Tax 20,000
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average 44.74
200-Day Moving Average n/a
Relative Strength Index (RSI) 53.88
Average Volume (20 Days) 131,766

Short Selling Information

The latest short interest is 230,983, so 2.49% of the outstanding shares have been sold short.

Short Interest 230,983
Short Previous Month 157,271
Short % of Shares Out 2.49%
Short % of Float 10.21%
Short Ratio (days to cover) 1.82

Income Statement

Revenue n/a
Gross Profit n/a
Operating Income -85.48M
Pretax Income -81.17M
Net Income -81.19M
EBITDA -73.39M
EBIT -80.93M
Earnings Per Share (EPS) -$27.99
Full Income Statement

Balance Sheet

The company has $142.35 million in cash and $35.92 million in debt, giving a net cash position of $106.43 million or $11.48 per share.

Cash & Cash Equivalents 142.35M
Total Debt 35.92M
Net Cash 106.43M
Net Cash Per Share $11.48
Equity (Book Value) 151.36M
Book Value Per Share 16.32
Working Capital 134.60M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$75.04 million and capital expenditures -$13.35 million, giving a free cash flow of -$88.40 million.

Operating Cash Flow -75.04M
Capital Expenditures -13.35M
Free Cash Flow -88.40M
FCF Per Share -$11.02
Full Cash Flow Statement

Margins

Gross Margin n/a
Operating Margin n/a
Pretax Margin n/a
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

Korro Bio does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield -2,853.58%
Shareholder Yield -2,853.58%
Earnings Yield -19.21%
FCF Yield -20.92%

Analyst Forecast

The average price target for Korro Bio is $122.50, which is 168.82% higher than the current price. The consensus rating is "Strong Buy".

Price Target $122.50
Price Target Difference 168.82%
Analyst Consensus Strong Buy
Analyst Count 4
Revenue Growth Forecast (5Y) n/a
EPS Growth Forecast (5Y) -27.17%
Stock Forecasts

Stock Splits

The last stock split was on November 6, 2023. It was a reverse split with a ratio of 1:50.

Last Split Date Nov 6, 2023
Split Type Reverse
Split Ratio 1:50

Scores

Altman Z-Score n/a
Piotroski F-Score 2